ArticleFrontiers in immunology2022

Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity.

Wen-Yu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.